Role of the CCL2-CCR2 signalling axis in cancer: Mechanisms and therapeutic targeting.
Xu M, Wang Y, Xia R, Wei Y, Wei X. · 2021
Read Role of the CCL2-CCR2 signalling axis in cancer: Mechanisms and therapeutic targeting. by Xu M, Wang Y, Xia R, Wei Y, Wei X. (2021) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/europmc-pmc8488570.txt.
Description
Xu and co-authors review the CCL2-CCR2 signaling axis in cancer and the drugs that target it. CCL2 is a chemokine, a signal that draws cells to move. Through its receptor CCR2, it can switch on tumor cell growth. It also helps cancer cells migrate to new sites.
Worse, the signal recruits immune-suppressing cells into the tumor area. That shields the tumor and favors its spread. Decades of studies have mapped this axis across many malignancies. Drugs that block it have shown promise in lab work and in trials. The review gathers those therapy results, with a focus on early studies.
Catalog record
| CREATOR | Xu M, Wang Y, Xia R, Wei Y, Wei X. |
|---|---|
| YEAR | 2021 |
| COLLECTION | PAPERS |
| FORMAT | TXT |
| FILE SIZE | 86 KB |
| LICENSE | CC BY 4.0 |
| RIGHTS | CC BY |
| SOURCE | Europe PMC |